Clinical Trials Logo

Clinical Trial Summary

This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.


Clinical Trial Description

This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death, initially in San Diego County with plans to expand nationally and internationally as funding allows. Genetic testing of the index subjects and their parents (or other biological family members if parents are not available) will be assessed for potential heritable causes of sudden death. By combining the wide catchment base of the San Diego Medical Examiner's Office, sequencing expertise of SD-based collaborators, computing power of the San Diego Supercomputer Center and in-house and external genomic analytics, the Scripps Translational Science Institute aims to provide a more complete characterization and understanding of the genetic causes of sudden death. Ultimately, findings from this study will be utilized to identify previously unrecognized mechanism of sudden death allowing for the development of preventative screening programs and potentially life-saving interventions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02168088
Study type Observational
Source Scripps Translational Science Institute
Contact Sarah Topol, RN
Phone 858-784-2155
Email topol.sarah@scrippshealth.org
Status Recruiting
Phase
Start date June 2014
Completion date June 2030